Question to the Department of Health and Social Care:

To ask Her Majesty's Government when the sub-committee of the Joint Committee on Vaccination and Immunisation which is investigating extending the human papillomavirus immunisation programme is expected to publish its conclusions and recommendations.

The Joint Committee on Vaccination and Immunisation (JCVI) Human papilloma virus (HPV) sub-committee will report its findings to JCVI following consideration of ongoing studies by Public Health England on the impact and cost-effectiveness of extending HPV vaccination to men who have sex with men (MSM) and/or adolescent boys.

It is expected that the MSM modelling study will be completed at the end of 2014 at the earliest, and the adolescent boys modelling study will be completed at the end of 2015 at the earliest. The JCVI will then consider the findings of the HPV subcommittee before deciding what advice or recommendations can be made.